I can't spoon feed any further. If you doubt ever step they're taking you should probably reassess your position.
Plexus don't deal in these regional markets (too small scale) nor China. They deal in US and EU. To date Plexus have vetted our potential US partners to mid pharma. This is why I'm here the rest is just upside.
SW is there to support the existing process already underway for regional deals only and not step on Plexus's toes. He'll contribute via applying his BS filter to potential partners. This is his wheelhouse and he'll add some additional professioniam and hustle to the process.
.
Ann: PAR Appoints Business Development Consultant, page-124
-
- There are more pages in this discussion • 204 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $82.20M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 23.0¢ | $85.35K | 365.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 280011 | 23.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 44703 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PAR (ASX) Chart |